Pharma
Amgen’s plans for €1bn Waterford campus in doubt
The US biotech giant says it will evaluate options following completion of €26 billion takeover of Horizon
Fresh fears have emerged that Amgen, the US biotech giant, will dramatically scale back a planned €1 billion campus in Waterford after it completed its acquisition of Horizon Therapeutics.
In a statement to the Business Post this weekend, the company said it will carry out a “network-wide evaluation” to assess whether it will go ahead with the investment, which was due to add 350 high-paid jobs to the city.
On Friday, the US drug company ...